rIX-FP

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

42 competitors in Hemophilia B

#DrugCompanyPhaseTrials

1

Recombinant Factor IX Coagulation

Pfizer

Approved

22

IB1001

MMedexus Pharma, Inc.

Phase 3

33

Translarna

PPTC Therapeutics

Phase 2

—4

BENEFIX

Pfizer

Phase 3

65

Recombinant Factor IX

BBaxalta now part of Shire

Phase 3

16

Rfix

Pfizer

Phase 3

37

Factor Ix

CSL Behring

Phase 3

38

Nonacog Alfa

Pfizer

Phase 3

39

Rfixfc

BBioverativ Therapeutics Inc.

Phase 3

410

RG7916

Roche

Phase 2

—Show 9 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hemophilia B3 trials

A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B

Completed·CSL Behring·Phase 3·NCT01662531·27 enrolled

A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Completed·CSL Behring·Phase 2/3·NCT01496274·63 enrolled

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Completed·CSL Behring·Phase 3·NCT02053792·97 enrolled

Details

Drug Info

Related News